CARISSA FEITEL: Open Payments
NPI 1285247700 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 3 | $159 |
| GENZYME CORPORATION | 4 | $123 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| Smith+Nephew, Inc. | 1 | $59 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ALK-Abello, Inc | 1 | $23 |
| Amgen Inc. | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Integra LifeSciences Corporation | 1 | $19 |
| Stryker Corporation | 1 | $15 |
Products named: DUPIXENT, Xhance, TULA, NUCALA, Odactra, NEFFY, ACCLARENT AERA, LATERA.
Industry payments across GA — which companies pay providers there.
